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Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) 
protein, like F508del-CFTR, disrupt intracellular trafficking leading to Cystic Fibrosis 
(CF) disease. Cells expressing F508de-CFTR restore their ability to exhibit forskolin-
dependent chloride transport at cell surface after treatment with a number of chemical an 
pharmacological chaperones known to stabilize proteins in their native conformation. 
Mutagenesis on arginine-framed tripeptides (AFTs or RXR) motifs, described to be 
involved in the endoplasmic reticulum (ER) retention/export quality control of many 
membrane proteins, was another effort to redirect F508del-CFTR to be functional at 
the cell membrane. The trafficking defect of F508del-CFTR is temperature-sensitive, 
as incubation at the permissive temperature of 27-30 °C results in partial protein export 
from the ER to the cell surface where it functions similarly to the wild-type protein.
Although the effects of all these strategies to rescue the defective F508del-CFTR 
trafficking and function are well documented the corresponding molecular mechanism 
is not fully elucidated. Proteins involved in the trafficking defect and/or rescue of 
CFTR mutants are potential CF therapeutic targets; therefore, we sought to identify 
these proteins.
We have investigated by proteomics whether BHK cells, the popular heterologous 
model system for examination of CFTR processing and function, underwent differential 
proteome modulation in response to the type of CFTR, i.e, wild-type-CFTR, F508del-
CFTR or F508del-4RK-CFTR, they are expressing and/or under effect of low 
temperature (LT) incubation (26ºC).
The results indicated that the mutagenic RXR reverted F508del-CFTR activates 
a particular unfolded protein response (UPR)/ ER stress pathway in BHK cells that 
might be able to generate a compatible and/or favourable cellular environment for 
(at least partial) F508del-CFTR rescuing. Most proteins involved are CFTR- and/
or 14-3-3-interactors, suggesting a potential role of these proteins in the CFTR 
trafficking.
Results from LT experiments showed that under 26ºC, BHK cells are metabolically 
active and may respond to temperature stress with different strategies from those at 
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37ºC, namely respecting CFTR processing and trafficking. LT expression profiles 
of several proteins in BHK-F508del cells tend to wt levels (37ºC), which can be 
indicative of the involvement of those proteins in rescue of CFTR. Many of them are 
also described as CFTR interactors (e.g. RACK1). The UPR in BHK-F508del cells 
under LT treatment seems also to be highly modulated, as many proteins involved in 
this mechanism were found up-regulated in LT conditions (e.g. GRP78). UPR appears 
to be particularly related to CFTR rescue by the enhancement of the chaperome/folding 
environment in the ER.
Several proteins identified in both experiments are also associated with CF 
inflammation and oxidative-stress pathology.
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